Coronavirus infections pass SARS; Trump’s peace plan; Anti-hypersonic research; Toll rises from Iran missile attack; And a bit more.

China’s new coronavirus has spread more widely than SARS almost two decades ago, but so far it is less deadly than SARS. “The number of confirmed cases jumped to 5,974, surpassing the 5,327 in mainland China during the SARS outbreak in 2002-2003,” AP reports this morning. “The death toll rose to 132, which is still lower than the 348 people who were killed in China by SARS.” 

Infected people outside China have been found in the United States (five cases), Australia, Cambodia, Canada, France, Germany, Ivory Coast, Japan, Malaysia, Nepal, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, and Vietnam. That's all according to the Washington Post, as of Tuesday afternoon EST.

Empty subways: The Atlantic has "Photos From Wuhan Under Quarantine," here

Airlines affected: British Airways became the first global airline to suspend flights to mainland China, the Wall Street Journal reports. CNN has more on other airlines affected this morning, including United Airlines, Lion Air, Seoul Air, Air Asia, Cathay Pacific, Air India and Finnair, here. And there’s this from USA Today this morning: “Flight full of Americans fleeing Wuhan coronavirus 'erupts in cheers' after arriving in Alaska.”

Nearly 200 people are being evacuated to March Air Reserve Base in California, DoD spokeswoman Alyssa Farah said in a Wednesday morning statement. They include U.S. Department of State employees, dependents and U.S. citizens evacuated from Wuhan, the epicenter of the outbreak. “Should routine monitoring of the evacuees identify ill individuals, the [U.S. Department of Health and Human Services] has procedures in place to transport them to a local civilian hospital.”

BTW: North Korea reportedly declared a national emergency due to the epidemic.

The U.S. has fast-tracked work on a possible vaccine, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Tuesday. But CNBC reports, “It could take a year or more before a vaccine is ready for sale to the public.” More here.

Know the lingo? According to NPR, "The Wuhan coronavirus outbreak has its own vocabulary. Here are definitions for some of the key words and phrases you might be hearing."

You may have heard some crazy things over the past couple days. That’s why four-dozen fact-checkers from 30 countries are fighting various bits of misinformation about the coronavirus, the Florida-based Poynter Institute for Media Studies announced Tuesday. “So far misinformation regarding the launch of a miraculous vaccine has been the largest trend, followed closely by a huge amount of fake data about the source of the fatal illness. Conspiracy theories come in third.” Read on, here.

And what film just made it to the top 10 list on iTunes movie rentals? The 2011 Steven Soderbergh drama/thriller, "Contagion." The Hollywood Reporter has more escapism, here


From Defense One

Pentagon Seeks a Way to Shoot Down Putin’s ‘Invincible’ Hypersonic Missiles // Patrick Tucker: A $13 million DARPA contract will get Northrop working on the problem.

Lockheed Has Best Year Ever, And Expects a Better 2020  // Marcus Weisgerber: Three years of defense spending increases show as the company’s sales hit nearly $60 billion.

Great Powers Must Talk to Each Other About AI // Elsa B. Kania and Andrew Imbrie: Even as they compete, major militaries have reason to cooperate: to avoid misunderstanding and to establish best practices and pragmatic parameters.

US Army Sleuths Seek Social-Media Search Services // Brandi Vincent, Nextgov: The Criminal Investigation Command is looking to tap into social media sites for digital evidence.

Welcome to this Wednesday edition of The D Brief from Ben Watson with Bradley Peniston. If you’re not already subscribed, you can do that here. On this day in 1820, the monarch who lost the American colonies, British King George III, died with dementia at the age of 81. 


The U.S. military recovered two bodies from near the E-11A crash site in Afghanistan’s Ghazni province, USFOR-A Spokesman Col. Sonny Leggett announced Tuesday. The flight data recorder was also recovered from the site, and “U.S. forces destroyed the remnants of the aircraft,” Leggett said. 
So far, "A mechanical issue is believed to have caused the E-11A to crash," a defense official told ABC News. "A second official told ABC News that the pilots had declared an in-flight emergency."

Sixteen more U.S. personnel have been diagnosed with traumatic brain injuries resulting from the Jan. 8 Iranian missile strikes on Iraqi bases, and all but one of those troops have returned to duty, CNN reported Tuesday afternoon. That raises the total TBI-affected troop count to 50. 
"Of these 50, 31 total service members were treated in Iraq and returned to duty, including 15 of the additional service members who have been diagnosed since the previous report," which was five days ago, Pentagon spokesman Lt. Col. Thomas Campbell said in a statement. "[Eighteen] service members have been transported to Germany for further evaluation and treatment. This is an increase of one service member from the previous report. As previously reported, one service member had been transported to Kuwait and has since returned to duty.”
There could be still more affected troops in the days ahead, CNN’s Barbara Starr reported. “Several Pentagon officials told CNN that the number of diagnosed cases is likely to continue to change. Approximately 200 people who were in the blast zone at the time of the attack have been screened for symptoms."
BTW: The VFW is still waiting for an apology from President Trump for his dismissive remarks about TBI last week in Davos, Switzerland. "And, we ask that he and the White House join with us in our efforts to educate Americans of the dangers TBI has on these heroes as they protect our great nation in these trying times. Our warriors require our full support more than ever in this challenging environment," William Schmitz, Veterans of Foreign Wars national commander, said last Friday in a statement. A bit more from CNN, here.

The White House unveiled its long-awaited plan for Israeli and Palestinian coexistence on Tuesday. The president’s son-in-law and the plan’s chief architect, Jared Kushner, went on CNN to talk about its prospects for success. If the Palestinians reject it, Kushner said to CNN’s Christiane Amanpour, “they’re going to screw up another opportunity, like they’ve screwed up every other opportunity that they’ve ever had in their existence.” 
Here is the White House’s overview and its full 181-page plan. And here's how the Washington Post’s Ishaan Tharoor summarizes the proposals: "Israel maintains sovereignty west of the Jordan river, a capital in an undivided Jerusalem, and control over Jewish enclaves and settlements scattered through the Palestinian territories. The Palestinians, meanwhile, get...not much....they would give up the claims of Palestinian refugees and accept a conditions-based path to statehood in a patchwork of territory carved up by Israeli roads and settlements.”
One big problem, according to the Wall Street Journal: “Trump on Tuesday said his plan would allow for a Palestinian capital in East Jerusalem. Yet the map released with the plan showed the boundaries of this Palestinian capital would begin only at the outskirts of the city and not include any part of the coveted old city, which contains important Muslim, Christian and Jewish holy sites.”
Surprise, surprise: “We say a thousand times, no, no, no to the deal of the century,” Palestinian Authority President Mahmoud Abbas announced Tuesday after the White House’s presentation. “We rejected this deal from the start and our stance was correct.”
Supporting the plan: the UK, Egypt and the UAE.
Not supporting the plan: Jordan and Turkey, as well as of course Hamas, the Islamist group that controls the Gaza Strip. Also the United Nations, which has long supported a two-state solution.
Worth noting: “The Palestinians were not just absent from this meeting” announcing the plan on Tuesday, the BBC’s defence correspondent Jonathan Marcus reports, “they have boycotted the Trump administration ever since it unilaterally moved its embassy to Jerusalem.” 
As things stand now, “they have essentially been presented with an ultimatum — accept the Trump parameters or else,” Marcus writes, “and they have been given some four years to come around.”
For Democratic Sen. Chris Murphy of Connecticut, the plan is “a total abandonment of decades of U.S. Middle East policy.” Murphy laid out his four main objections — including that it “was negotiated with no one but the Israelis” — in a Twitter thread, here

Leadership failures are to blame for certain “unacceptable conduct” among America’s special operators, Gen. Richard Clarke, the head of Special Operations Command, explained (CNN) Tuesday “in a memo to service members that accompanied [a] 71-page report documenting the initial findings of a comprehensive ethics review he ordered last August following a flurry of incidents, including allegations of sexual assault and cocaine use against Navy SEAL team members."
"Certain aspects of our culture have, at times, set conditions favorable for inappropriate behavior," Clarke told reporters Tuesday. "Nearly twenty years of continuous conflict have imbalanced that culture to favor force employment and mission accomplishment over the routine activities that ensure leadership, accountability, and discipline. This is a problem, and our review team recommended more than a dozen ways to address it... Most importantly, we need to improve our leader development programs and improve accountability in our training and management processes." More at CNN, here.
Speaking of: In a video posted to Facebook and Instagram on Monday, retired Navy SEAL Eddie Gallagher referred to some members of his former platoon as “cowards” and highlighted names, photos and their duty status and current units, potentially putting them in jeopardy, the San Diego Union-Tribune reported Monday. (FWIW: “The video appears to be a trailer for an unspecified future project,” SDUT notes.)
Related: Navy SEAL Promoted After Choking Green Beret to Death.” That’s The Daily Beast’s headline for a report on Chief Petty Officer Tony DeDolph, who “was formally charged in November 2018 with felony murder, conspiracy, obstruction of justice, burglary, hazing, and involuntary manslaughter in the strangulation death of Army Staff Sgt. Logan Melgar, a Special Forces soldier assigned to the 3rd Special Forces Group.” 

And finally today: $50K per month to spy for China? A nanotechnology researcher who was also the chair of Harvard’s chemistry department was arrested by the FBI on Tuesday for lying to the Defense Department and the National Institutes of Health about his contacts with China’s Thousand Talents Program. Read over the charges, here.
What’s going on: The New York Times writes “The arrest of Charles M. Lieber, the chair of Harvard’s department of chemistry and chemical biology, signaled a new, aggressive phase in the Justice Department’s campaign to root out scientists who are stealing research from American laboratories.”
“The case was one of three presented Tuesday by federal authorities in Massachusetts,” the Wall Street Journal reports, “with each underscoring U.S. concerns that the Chinese government is trying to obtain cutting-edge U.S. research by exploiting U.S. universities and their professors and researchers.”
About those other two: “Zaosong Zheng, a Harvard-affiliated cancer researcher was caught leaving the country with 21 vials of cells stolen from a laboratory at Beth Israel Deaconess Hospital in Boston,” the Times reports. Those vials were found wrapped in a sock. “The third was Yanqing Ye, who had been conducting research at Boston University’s department of physics, chemistry and biomedical engineering until last spring, when she returned to China. Prosecutors said she hid the fact that she was a lieutenant in the People’s Liberation Army, and continued to carry out assignments from Chinese military officers while at B.U.”
“The charges brought by the U.S. government against Professor Lieber are extremely serious,” a Harvard spokesman told the Times. “Harvard is cooperating with federal authorities, including the National Institutes of Health, and is initiating its own review of the alleged misconduct.”
In case you’re just catching up, the Journal reminds us that “Through its government-backed Thousand Talents Plan and hundreds of similar programs, China pays scientists around the world to moonlight at Chinese institutions, often without disclosing the work to their primary employers.”
Show me the money: "As part of the Thousand Talents program, Wuhan University of Technology gave Mr. Lieber more than $1.5 million to set up a research lab in China,” WSJ writes. “The school also agreed to pay him a $50,000 monthly salary and offered about $150,000 in annual living expenses for ‘significant periods’ from 2012 to 2017."
Bigger picture consideration: “While we are still confronted with traditional spies,” said Joseph Bonavolonta, who runs the FBI’s Boston office, “I can tell you China is also using what we call nontraditional collectors such as professors, researchers, hackers and front companies.” More here.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.